| EPIC | OXB |
| Sector | Pharma and Biotech |
| ISIN | GB00BDFBVT43 |
| Market Sector | MAIN |
| Market Segment | SSMM |
| Main Indices | techMARK, FTSE 250, FTSE 350, FTSE All-Share, FTSE techMARK Focus |
| Country of register | Great Britain |
| Currency | British Pound |
| Market Cap | £625.83m |
| NMS | 2,000 |
| Shares in issue | 121.05m |
| Date Listed | 17-Apr-2001 |
| Currency | UK Pounds |
| Share Price | 517.00p |
| Change Today | -11.00p |
| % Change | -2.08 % |
| 52 Week High | 913.00 |
| 52 Week Low | 424.00 |
| Volume | 139,520 |
| Shares Issued | 121.05m |
| Market Cap | £625.83m |
| Beta | 0.03 |
| RiskGrade | 125 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 3 |
| Buy | 1 |
| Neutral | 4 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 8 |

| No dividends found |
| Time | Volume / Share Price |
| 13:32 | 3,423 @ 518.90p |
| 13:22 | 82 @ 517.00p |
| 13:22 | 83 @ 517.00p |
| 13:22 | 79 @ 517.00p |
| 13:22 | 4 @ 517.00p |
| Chair | Roch Doliveux |
| CEO | Frank Mathias |
| CFO | Lucinda (Lucy) Crabtree |
You are here: research